Correlation Between Neurocrine Biosciences and Goliath Film

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Goliath Film at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Goliath Film into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Goliath Film and, you can compare the effects of market volatilities on Neurocrine Biosciences and Goliath Film and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Goliath Film. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Goliath Film.

Diversification Opportunities for Neurocrine Biosciences and Goliath Film

-0.68
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neurocrine and Goliath is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Goliath Film and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Goliath Film and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Goliath Film. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Goliath Film has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Goliath Film go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Goliath Film

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.3 times more return on investment than Goliath Film. However, Neurocrine Biosciences is 3.31 times less risky than Goliath Film. It trades about 0.13 of its potential returns per unit of risk. Goliath Film and is currently generating about -0.06 per unit of risk. If you would invest  11,775  in Neurocrine Biosciences on September 22, 2024 and sell it today you would earn a total of  1,721  from holding Neurocrine Biosciences or generate 14.62% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.46%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Goliath Film and

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Goliath Film 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Goliath Film and has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's primary indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Neurocrine Biosciences and Goliath Film Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Goliath Film

The main advantage of trading using opposite Neurocrine Biosciences and Goliath Film positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Goliath Film can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Goliath Film will offset losses from the drop in Goliath Film's long position.
The idea behind Neurocrine Biosciences and Goliath Film and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments